Toward a more precise immunophenotypic and molecular definition of human cMoPs
Cell Reports · 2026
DOI: 10.1016/j.celrep.2026.117970 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2026. Verfasst von Federica Calzetti und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Section of General Pathology, University of Verona, 37134 Verona, Italy. Hauptthemen laut MEDLINE: Monocytes, Immunophenotyping, Hematopoietic Stem Cells. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministero dell'Istruzione dell'Università e della Ricerca, AIRC Foundation for Cancer Research, Associazione Italiana per la Ricerca sul Cancro.
Abstract (Originalsprache)
Monocytes arise from hematopoietic progenitors in the bone marrow and play crucial roles in both homeostasis and inflammation. Human common monocyte progenitors (cMoPs) were originally identified as CLEC12A+CD64hi cells but have recently been redefined as CD115+CD64hi/int cells. We therefore evaluated whether CLEC12A+CD64hi cMoPs and CD115+CD64hi/int cMoPs represent the same cell type using flow cytometry, scRNA-seq, morphological, and functional analyses. We demonstrate that including CD115 in the gating strategy, rather than CLEC12A, yields a more accurate definition of cMoPs. Differentiation assays demonstrate the transition of CD115+CD64int cMoPs into CD115+CD64hi cMoPs and a comparable capacity for the two cMoPs to generate monocyte progeny. scRNA-seq clustering of the CD115+CD64hi/int cMoPs identified five different transcriptional features including maturation-associated programs, IFN response and stress-related genes. ATAC-seq analysis of CD115+CD64hi/int cMoPs identified IRF8, PU.1, and also C/EBPδ as transcription factors putatively involved in monocyte development. Based on a more accurate definition and analysis, our data demonstrate the molecular complexity of human cMoPs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Section of General Pathology, University of Verona, 37134 Verona, Italy.
- Centro Piattaforme Tecnologiche, University of Verona, 37134 Verona, Italy.
- Department of Engineering for Innovation Medicine, University of Verona, 37134 Verona, Italy.
- Biological Technology Department, Research Division, Chugai Life Science Park Yokohama, Chugai Pharmaceutical Co. Ltd, Kanagawa 244-8602, Japan; Department of Biodefense Research, Medical Research Laboratory, Institute…
- Monocytomics Research, 82211 Herrsching, Germany.
- Department of Biodefense Research, Medical Research Laboratory, Institute of Integrated Research, Institute of Science Tokyo, Tokyo 113-8510, Japan. Electronic address: ohteki.bre@mri.tmd.ac.jp.
Förderung
- Ministero dell'Istruzione dell'Università e della Ricerca
- AIRC Foundation for Cancer Research
- Associazione Italiana per la Ricerca sul Cancro
Zitieren
APA
Calzetti, F., Signoretto, I., Finotti, G., Bianchetto-Aguilera, F., Angelini, G., Lattanzi, C., Gasperini, S., Gardiman, E., Tecchio, C., Kawamura, S., Ziegler-Heitbrock, L., Tamassia, N., Ohteki, T., & Cassatella, M. A. (2026). Toward a more precise immunophenotypic and molecular definition of human cMoPs. Cell Reports. https://doi.org/10.1016/j.celrep.2026.117970
Vancouver
Calzetti F, Signoretto I, Finotti G, Bianchetto-Aguilera F, Angelini G, Lattanzi C, et al. Toward a more precise immunophenotypic and molecular definition of human cMoPs. Cell Reports. 2026. doi:10.1016/j.celrep.2026.117970
BibTeX
@article{Calzetti2026,
author = {Calzetti, Federica and Signoretto, Ilaria and Finotti, Giulia and Bianchetto-Aguilera, Francisco and Angelini, Gabriele and Lattanzi, Chiara and Gasperini, Sara and Gardiman, Elisa and Tecchio, Cristina and Kawamura, Shunsuke and Ziegler-Heitbrock, Loems and Tamassia, Nicola and Ohteki, Toshiaki and Cassatella, Marco A},
title = {Toward a more precise immunophenotypic and molecular definition of human cMoPs},
journal = {Cell Reports},
year = {2026},
doi = {10.1016/j.celrep.2026.117970}
}
EUVIMED